Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab

BACKGROUND: There is an unmet need to identify markers that predict the response to nivolumab in patients with non-small-cell lung cancer (NSCLC). The neutrophil-to-lymphocyte ratio (NLR) was recently recognized as an indicator of a poor prognosis in patients with various cancers. In the present stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Aya, Kurata, Takayasu, Yoshioka, Hiroshige, Takeyasu, Yuki, Niki, Maiko, Kibata, Kayoko, Satsutani, Naoko, Ogata, Makoto, Miyara, Takayuki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097082/
https://www.ncbi.nlm.nih.gov/pubmed/29442281
http://dx.doi.org/10.1007/s10147-018-1250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097082/
https://www.ncbi.nlm.nih.gov/pubmed/29442281
http://dx.doi.org/10.1007/s10147-018-1250-2

Ejemplares similares